Anita J Brogan

4PUBLICATIONS
8CO-AUTHORS
Disease surveillanceApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Behavioural epidemiologyNaturopathy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jan 24, 2024
Cost-effectiveness of Cabotegravir Long-Acting for HIV Pre-exposure Prophylaxis in the United States.

Anita J Brogan, Ashley E Davis, Claire E Mellott

|Feb 03, 2021
The Cost-Effectiveness and Budget Impact of Ibalizumab-uiyk for Adults with Multidrug-Resistant HIV-1 Infection in the United States.

Anita J Brogan, Sandra E Talbird, Ashley E Davis

|Aug 09, 2019
Is increased screening and early antiretroviral treatment for HIV-1 worth the investment? An analysis of the public health and economic impact of improvement in the UK.

A J Brogan, S E Talbird, A E Davis

|Aug 31, 2018
Short-term cost analysis of raltegravir versus atazanavir + ritonavir or darunavir + ritonavir for treatment-naive adults with HIV-1 infection in the United States.

Anita J Brogan, Ashley E Davis, Bridgett Goodwin

Pageof 1

Frequent Collaborators

2 joint publications

Ashley E Davis

1 joint publications

Sandra E Talbird

1 joint publications

Elizabeth M La

1 joint publications

Princy N Kumar